Shahana Majid, PhD

Title(s)Associate Professor, Urology
SchoolSchool of Medicine
Address4150 Clement St
San Francisco CA 94121
Phone415-221-4810 ext. 3282
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, San FranciscoAssociate Professor2018Urological cancers
    University of California, San Francisco, San FranciscoAssistant Professor2012Urological cancers
    University of California, San Francisco, San FranciscoPost Doctoral Fellow/Research Fellow2006Urological cancers
    American Biological Safety Association (ABSA International)Registered Biosafety Professional06/2020Biological Safety

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A lncRNA TCL6-miRNA-155 interaction regulates the Src-Akt-EMT network to mediate kidney cancer progression and metastasis. Cancer Res. 2021 Jan 26. Kulkarni P, Dasgupta P, Hashimoto Y, Shiina M, Shahryari V, Tabatabai ZL, Yamamura S, Tanaka Y, Saini S, Dahiya R, Majid S. PMID: 33500248.
      View in: PubMed   Mentions:    Fields:    
    2. Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells. Toxicol Appl Pharmacol. 2020 12 15; 409:115308. Kulkarni P, Dasgupta P, Bhat NS, Hashimoto Y, Saini S, Shahryari V, Yamamura S, Shiina M, Tanaka Y, Dahiya R, Majid S. PMID: 33129824.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer. Oncogene. 2020 12; 39(49):7209-7223. PMID: 33037409.
      View in: PubMed   Mentions:    Fields:    
    4. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Cell Death Dis. 2020 08 19; 11(8):660. Dasgupta P, Kulkarni P, Majid S, Hashimoto Y, Shiina M, Shahryari V, Bhat NS, Tabatabai L, Yamamura S, Saini S, Tanaka Y, Dahiya R. PMID: 32814766.
      View in: PubMed   Mentions:    Fields:    
    5. Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer. Toxicol Appl Pharmacol. 2020 08 15; 401:115102. Dasgupta P, Kulkarni P, Bhat NS, Majid S, Shiina M, Shahryari V, Yamamura S, Tanaka Y, Gupta RK, Dahiya R, Hashimoto Y. PMID: 32512071.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    6. Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney Cancer. Cell Physiol Biochem. 2020 01 22; 54(1):53-70. Imai-Sumida M, Dasgupta P, Kulkarni P, Shiina M, Hashimoto Y, Shahryari V, Majid S, Tanaka Y, Dahiya R, Yamamura S. PMID: 31961100.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    7. Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients. J Vis Exp. 2019 11 19; (153). Bhagirath D, Dahiya R, Majid S, Tabatabai ZL, Saini S. PMID: 31814621.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma. Oncogenesis. 2019 Aug 13; 8(8):42. Ursu S, Majid S, Garger C, de Semir D, Bezrookove V, Desprez PY, McAllister S, Soroceanu L, Nosrati M, Yimam K, Hassoun A, Osorio R, Kashani-Sabet M, Dar AA. PMID: 31409772.
      View in: PubMed   Mentions:
    9. BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2. Clin Cancer Res. 2019 11 01; 25(21):6532-6545. Bhagirath D, Yang TL, Tabatabai ZL, Majid S, Dahiya R, Tanaka Y, Saini S. PMID: 31371344.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression. Carcinogenesis. 2019 07 04; 40(5):633-642. Bhagirath D, Yang TL, Tabatabai ZL, Shahryari V, Majid S, Dahiya R, Tanaka Y, Saini S. PMID: 30874288.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    11. Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer. Cancer Prev Res (Phila). 2019 09; 12(9):585-598. Hashimoto Y, Shiina M, Dasgupta P, Kulkarni P, Kato T, Wong RK, Tanaka Y, Shahryari V, Maekawa S, Yamamura S, Saini S, Deng G, Tabatabai ZL, Majid S, Dahiya R. PMID: 31266828.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    12. Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer. J Cell Mol Med. 2018 10; 22(10):4676-4687. Kato T, Hashimoto Y, Wong RK, Mitsui Y, Maekawa S, Chang I, Shahryari V, Yamamura S, Majid S, Saini S, Tabatabai ZL, Dahiya R, Deguchi T, Tanaka Y. PMID: 30133114.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Mol Cancer Res. 2018 11; 16(11):1750-1760. Kulkarni P, Dasgupta P, Bhat NS, Shahryari V, Shiina M, Hashimoto Y, Majid S, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. PMID: 30037856.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    14. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma. . 2018 05; 17(5):1061-1069. Dasgupta P, Kulkarni P, Majid S, Shahryari V, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. PMID: 29440295.
      View in: PubMed   Mentions:
    15. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res. 2018 04 01; 78(7):1833-1844. Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S. PMID: 29437039.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    16. Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Oncotarget. 2017 Nov 03; 8(54):92032-92042. PMID: 29190895.
      View in: PubMed   Mentions: 6     Fields:    
    17. MicroRNA-720 Regulates E-cadherin-aE-catenin Complex and Promotes Renal Cell Carcinoma. . 2017 Dec; 16(12):2840-2848. Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. PMID: 28802251.
      View in: PubMed   Mentions:
    18. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Cell Death Differ. 2017 07; 24(7):1263-1274. PMID: 28498363.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    19. The role of miR-24 as a race related genetic factor in prostate cancer. Oncotarget. 2017 Mar 07; 8(10):16581-16593. PMID: 28157714.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    20. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma. Mol Cancer Res. 2017 07; 15(7):884-895. PMID: 28242813.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    21. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians. Oncotarget. 2017 Jan 31; 8(5):8356-8368. PMID: 28039468.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    22. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death Dis. 2017 01 26; 8(1):e2572. PMID: 28125091.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    23. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Oncogene. 2017 05 11; 36(19):2667-2679. PMID: 27893706.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    24. Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer. Oncotarget. 2016 Oct 25; 7(43):70388-70403. PMID: 27611943.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    25. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer. Oncotarget. 2016 Oct 18; 7(42):68371-68384. PMID: 27634912.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    26. MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Oncotarget. 2016 Oct 11; 7(41):67597-67611. PMID: 27588490.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    27. Pre-clinical Orthotopic Murine Model of Human Prostate Cancer. J Vis Exp. 2016 Aug 29; (114). PMID: 27684100.
      View in: PubMed   Mentions: 1     Fields:    
    28. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. Oncotarget. 2016 Aug 02; 7(31):49107-49121. PMID: 27203547.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    29. BPTF transduces MITF-driven prosurvival signals in melanoma cells. Proc Natl Acad Sci U S A. 2016 May 31; 113(22):6254-8. PMID: 27185926.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    30. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Oncotarget. 2016 Apr 12; 7(15):19519-30. PMID: 26799586.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    31. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015 Dec 01; 15:942. PMID: 26626260.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    32. miRNA Expression Analyses in Prostate Cancer Clinical Tissues. J Vis Exp. 2015 Sep 08; (103). PMID: 26382040.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    33. Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells. Oncotarget. 2015 Jun 30; 6(18):16341-51. PMID: 26036629.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    34. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget. 2015 Apr 20; 6(11):9577-91. PMID: 25797254.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    35. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy. J Natl Cancer Inst. 2015 Feb 23; 107(5). PMID: 25713167.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    36. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. Oncotarget. 2014 Nov 30; 5(22):11297-307. PMID: 25526032.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    37. Antitumor activity of miR-1280 in melanoma by regulation of Src. Mol Ther. 2015 Jan; 23(1):71-8. PMID: 25195599.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    38. MicroRNA-mediated regulation of melanoma. Br J Dermatol. 2014 Aug; 171(2):234-41. PMID: 24665835.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    39. Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumour Biol. 2014 Oct; 35(10):10223-30. PMID: 25027399.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. . 2014 Jul; 13(7):1952-63. PMID: 24817628.
      View in: PubMed   Mentions:
    41. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014 May 02; 289(18):12550-65. PMID: 24616104.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    42. MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases. PLoS One. 2013; 8(11):e78023. PMID: 24223753.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    43. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One. 2013; 8(8):e70372. PMID: 23936419.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    44. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One. 2013; 8(7):e67686. PMID: 23844063.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    45. Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells. . 2013 Jun; 12(6):1049-59. PMID: 23580416.
      View in: PubMed   Mentions:
    46. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One. 2013; 8(3):e58929. PMID: 23554959.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    47. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst. 2013 Mar 20; 105(6):433-42. PMID: 23365201.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    48. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 2012; 7(11):e50203. PMID: 23189187.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    49. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res. 2013 Jan 01; 19(1):73-84. PMID: 23147995.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    50. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res. 2012 Dec 15; 72(24):6435-46. PMID: 23074286.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    51. MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One. 2012; 7(10):e46743. PMID: 23056431.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    52. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One. 2012; 7(8):e43812. PMID: 22928040.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    53. miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res. 2012 Jul 15; 72(14):3618-30. PMID: 22552290.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    54. Wnt signaling pathways in urological cancers: past decades and still growing. Mol Cancer. 2012 Feb 10; 11:7. PMID: 22325146.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    55. Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One. 2012; 7(2):e31060. PMID: 22347428.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    56. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One. 2012; 7(1):e29722. PMID: 22235332.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    57. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis. 2012 Feb; 33(2):294-300. PMID: 22159222.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    58. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Carcinogenesis. 2012 Feb; 33(2):420-6. PMID: 22159223.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    59. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. . 2012 Jan; 11(1):244-53. PMID: 22057916.
      View in: PubMed   Mentions:
    60. The complex roles of Wnt antagonists in RCC. Nat Rev Urol. 2011 Oct 25; 8(12):690-9. PMID: 22025172.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    61. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res. 2011 Oct 01; 71(19):6208-19. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R. PMID: 21852381.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    62. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila). 2011 Oct; 4(10):1698-709. PMID: 21836020.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    63. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer. 2011 Apr 15; 128(8):1793-803. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, Saini S, Majid S, Deng G, Ishii N, Dahiya R. PMID: 20549706.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    64. IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma. Int J Cancer. 2011 Nov 15; 129(10):2360-9. Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, Dahiya R. PMID: 21207373.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    65. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem. 2011 May 13; 286(19):16606-14. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M. PMID: 21454583.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    66. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res. 2011 Apr 01; 71(7):2611-21. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R. PMID: 21330408.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    67. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer. 2011 Feb 01; 128(3):541-50. Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. PMID: 20340127.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    68. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol Carcinog. 2011 Jun; 50(6):449-57. PMID: 21268126.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    69. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res. 2011 Aug 15; 17(16):5287-98. PMID: 21159887.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansAnimalsCells
    70. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila). 2011 Jan; 4(1):76-86. PMID: 21071579.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    71. DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma. Cancer. 2011 Apr 15; 117(8):1649-60. Hirata H, Hinoda Y, Majid S, Chen Y, Zaman MS, Ueno K, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R. PMID: 21472712.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    72. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer. 2010 Dec 15; 116(24):5637-49. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, Deng G, Dahiya R. PMID: 20737563.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    73. The functional significance of microRNA-145 in prostate cancer. Br J Cancer. 2010 Jul 13; 103(2):256-64. Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S, Majid S, Liu J, Khatri G, Tanaka Y, Dahiya R. PMID: 20588276.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    74. Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer. Carcinogenesis. 2010 Sep; 31(9):1620-6. Hirata H, Hinoda Y, Zaman MS, Chen Y, Ueno K, Majid S, Tripsas C, Rubin M, Chen LM, Dahiya R. PMID: 20554747.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    75. Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer. . 2010 Jun; 9(6):1680-7. Yamamura S, Kawakami K, Hirata H, Ueno K, Saini S, Majid S, Dahiya R. PMID: 20501806.
      View in: PubMed   Mentions:
    76. Functional modulation of IGF-binding protein-3 expression in melanoma. J Invest Dermatol. 2010 Aug; 130(8):2071-9. Dar AA, Majid S, Nosrati M, de Semir D, Federman S, Kashani-Sabet M. PMID: 20357812.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    77. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010 Apr 01; 70(7):2809-18. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, Tanaka Y, Dahiya R. PMID: 20332239.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    78. Diet, microRNAs and prostate cancer. Pharm Res. 2010 Jun; 27(6):1014-26. Saini S, Majid S, Dahiya R. PMID: 20221895.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    79. Role of secreted frizzled-related protein 3 in human renal cell carcinoma. Cancer Res. 2010 Mar 01; 70(5):1896-905. Hirata H, Hinoda Y, Ueno K, Majid S, Saini S, Dahiya R. PMID: 20160027.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    80. Aurora kinase inhibitors--rising stars in cancer therapeutics? . 2010 Feb; 9(2):268-78. Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W. PMID: 20124450.
      View in: PubMed   Mentions:
    81. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 2010 Jan 01; 116(1):66-76. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R. PMID: 19885928.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    82. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res. 2009 Nov 15; 69(22):8603-10. Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. PMID: 19887605.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    83. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin Cancer Res. 2009 Sep 15; 15(18):5678-87. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, Ishii N, Dahiya R. PMID: 19755393.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    84. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas. Cancer Res. 2009 Sep 01; 69(17):6815-22. Saini S, Liu J, Yamamura S, Majid S, Kawakami K, Hirata H, Dahiya R. PMID: 19723665.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    85. Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis. Cancer Res. 2009 Sep 01; 69(17):7038-45. Saini S, Hirata H, Majid S, Dahiya R. PMID: 19690133.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    86. Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer. Biochem Biophys Res Commun. 2009 Jun 12; 383(4):440-4. Tanaka Y, Zaman MS, Majid S, Liu J, Kawakami K, Shiina H, Tokizane T, Dahiya AV, Sen S, Nakajima K. PMID: 19364498.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    87. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009 Apr; 30(4):662-70. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R. PMID: 19221000.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    88. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008 Apr 15; 68(8):2736-44. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, Hirata H, Li LC, Zhao H, Okino ST, Place RF, Pookot D, Dahiya R. PMID: 18413741.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    89. Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog. 2007 Oct; 46(10):839-46. Okino ST, Pookot D, Majid S, Zhao H, Li LC, Place RF, Dahiya R. PMID: 17415778.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    90. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene. 2007 Dec 06; 26(55):7647-55. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M, Dahiya R. PMID: 17563745.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    91. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res. 2007 May 01; 13(9):2541-8. Kawamoto K, Okino ST, Place RF, Urakami S, Hirata H, Kikuno N, Kawakami T, Tanaka Y, Pookot D, Chen Z, Majid S, Enokida H, Nakagawa M, Dahiya R. PMID: 17473182.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    92. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):92-7. Tanaka Y, Hirata H, Chen Z, Kikuno N, Kawamoto K, Majid S, Tokizane T, Urakami S, Shiina H, Nakajima K, Dhir R, Dahiya R. PMID: 17220335.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    93. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer. 2007 Jan; 43(2):231-7. Hirata H, Hinoda Y, Tanaka Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Majid S, Vejdani K, Dahiya R. PMID: 17196815.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    94. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res. 2006 Dec 01; 12(23):6989-97. Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R. PMID: 17145819.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    Shahana's Networks
    Concepts (350)
    Derived automatically from this person's publications.
    Co-Authors (9)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department